ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 128 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $12,000 | -42.9% | 976 | 0.0% | 0.00% | – |
| Q2 2021 | $21,000 | -22.2% | 976 | 0.0% | 0.00% | – |
| Q1 2021 | $27,000 | -25.0% | 976 | -28.6% | 0.00% | – |
| Q4 2020 | $36,000 | -29.4% | 1,366 | 0.0% | 0.00% | – |
| Q3 2020 | $51,000 | -27.1% | 1,366 | 0.0% | 0.00% | – |
| Q2 2020 | $70,000 | -89.1% | 1,366 | -91.7% | 0.00% | -100.0% |
| Q2 2018 | $642,000 | -82.9% | 16,395 | -68.3% | 0.00% | -85.7% |
| Q1 2018 | $3,744,000 | +174.5% | 51,759 | +149.9% | 0.01% | +250.0% |
| Q4 2017 | $1,364,000 | +16.7% | 20,711 | -11.2% | 0.00% | 0.0% |
| Q3 2017 | $1,169,000 | -1.1% | 23,329 | -8.7% | 0.00% | 0.0% |
| Q2 2017 | $1,182,000 | – | 25,549 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,679,835 | $69,675,000 | 19.39% |
| Endurant Capital Management LP | 207,293 | $5,390,000 | 1.94% |
| Bellevue Group AG | 5,138,451 | $133,599,000 | 1.53% |
| Rhenman & Partners Asset Management AB | 592,225 | $15,398,000 | 1.26% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,562,869 | $40,635,000 | 0.93% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 31,434 | $817,000 | 0.62% |
| WASATCH ADVISORS LP | 3,998,010 | $103,949,000 | 0.51% |
| HAMILTON LANE ADVISORS LLC | 46,181 | $1,201,000 | 0.45% |
| Boxer Capital, LLC | 500,000 | $13,000,000 | 0.42% |
| DCF Advisers, LLC | 38,500 | $1,001,000 | 0.41% |